Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 30.92 | N/A |
| PEG Ratio (TTM) | 2.69 | N/A |
| P/S Ratio (TTM) | 1.19 | N/A |
| P/B Ratio (TTM) | 1.59 | N/A |
| P/FCF Ratio (TTM) | 13.26 | N/A |
| Price to 5YR AVG Earnings Ratio | 32.85 | N/A |
| Price to 5YR AVG FCF Ratio | 13.85 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.61% | N/A |
| ROE (TTM) | 5.21% | N/A |
| Net Profit Margin (TTM) | 3.85% | N/A |
| ROIC 5YR AVG | 7.34% | N/A |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 35.10% | -81.96% | 10.19% |
| Revenue | 0.42% | 0.62% | 0.74% |
| Net Income | 34.13% | -81.95% | 9.02% |
| Cash Flow | 43.24% | -5.29% | -1.31% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.51 | N/A |
| Quick Ratio (TTM) | 1.51 | N/A |
| D/E Ratio (TTM) | 0.67 | N/A |
| Interest Coverage (TTM) | 2.94 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.79 | N/A |
| LTL to 5YR AVG FCF | 6.84 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.80% | N/A |